University inventor: Tim O’Brian, Beth Lindborg, Amanda Vegoe Sarcio Technologies (formerly Superior Organoid Technologies) Use of Modified Extracellular Vehicles to Boost Immune Response in Colorectal Cancer. Polymer-based, nonviral systems for binding, encapsulation, and delivery of biomolecular payloads in a well-defined manner and in an efficient and low cost manner compared to viral delivery systems.īusiness will enable the creation of humanized organs in pigs including heart, skeletal tissues, vasculature and blood products. Treatment of metabolic and cardiovascular complications of peripheral arterial disease using a synthetically engineered natriuretic peptide. Therapy for the treatment of diastolic dysfunction.Ī surgically implanted tissue support structure for regenerative medicine-based treatment approaches to macular degeneration.īiological sample processing technologies, including bio-sampling, bio-separation, and bioconcentration to enable rapid and remote diagnostics. Non-DMSO cryopreservation product that increases the viability of preserved cells for future delivery to cell and gene therapy patients. University inventors: Allison Hubel, Kathryn Pollock University inventors: Jon Hawkinson, Gurpreet Singh, Michael Waltersĭrug that slows the progression of calcification in people with aortic valve stenosis Use of CD200 inhibitors for canine cancers. University inventors: Michael Olin, Christopher Moertel University inventors: Jaime Modiano, Taylor Depauw, Ali KhammanivongĪrtificial Intelligence for Early Cancer Detection in canines. Mereddy's laboratory into cancer therapies. University inventors: Zachary Gardner, Venkatram Mereddy, Tanner SchumacherĬonnuct Ltd was started by two prospective investors to advance small molecules from Dr.

Ten UMN startups have been acquired or have gone public since 2017, underscoring the relevance of University innovations and technologies. We have launched more than 200 startups (video) based on UMN research since the Venture Center was formed in 2006, with more than $1.8 billion raised in investment capital, IPOs and acquisitions (2022 survey).

Subree subramanian rate umn